Expression of CD90 and its clinical significance in different molecular subtypes of breast invasive ductal carcinoma
10.13315/j.cnki.cjcep.2017.03.003
- VernacularTitle:乳腺浸润性导管癌不同分子分型中CD90的表达及其意义
- Author:
Haiyu YANG
;
Yong LIU
;
Yanzhi DAI
;
Xiaoxia WU
;
Tao HUANG
;
Sheng YUAN
- Keywords:
breast neoplasm;
CD90;
molecular subtyping;
metastasis;
immunohistochemistry
- From:
Chinese Journal of Clinical and Experimental Pathology
2017;33(3):245-249
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To detect the expression of CD90 in invasive ductal breast carcinoma with different molecular subtypes and to explore its clinical significance.Methods The expression of CD90,ER,PR,Ki-67 and HER-2 were detected in 80 cases of invasive ductal breast carcinoma tissue and 20 cases of breast benign lesion with immunohistochemical method.The relationship between CD90 and clinicopathological parameters were analyzed.Results The positive expression rate of CD90 in invasive ductal breast carcinoma and breast benign lesion tissues were 62.5％ and 20.0％,respectively (P ＜0.001).The expression of CD90 in invasive ductal breast carcinoma was correlated with lymph node metastasis (P ＜ 0.05),but not with age,tumor size,TNM staging and histological grade (P ＞ 0.05).Among different molecular subtypes,CD90 expression level in Luminal A type was the lowest (40.0％),and the level in triple negative type was the highest (82.4％) (P ＜0.05).CD90 expression level was negatively correlated with ER (r=-0.342,P＜0.05) orPR (r=-0.374,P＜0.05) expression level,but not with Ki-67 (r =0.084,P ＞ 0.05).Condusion The over-expression of CD90 is related with molecular subtypes of breast carcinoma,and its high expression suggests a poor prognosis.
